Bradley G. Somer

3.4k total citations
45 papers, 1.3k citations indexed

About

Bradley G. Somer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bradley G. Somer has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Bradley G. Somer's work include Prostate Cancer Treatment and Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Bradley G. Somer is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Bradley G. Somer collaborates with scholars based in United States, Germany and South Korea. Bradley G. Somer's co-authors include Stephen J. Schuster, Donald E. Tsai, Christine Hardy, Robert M. Kotloff, Kathleen T. Montone, John E. Tomaszewski, David Porter, Edward A. Stadtmauer, M. E. Scheulen and Joon Oh Park and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Bradley G. Somer

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bradley G. Somer United States 16 808 412 304 279 192 45 1.3k
Lisa Rodríguez United States 12 615 0.8× 287 0.7× 318 1.0× 250 0.9× 160 0.8× 20 1.1k
Vanja Vaccaro Italy 15 780 1.0× 491 1.2× 312 1.0× 301 1.1× 102 0.5× 30 1.2k
Kim A. Reiss United States 19 971 1.2× 452 1.1× 226 0.7× 444 1.6× 135 0.7× 63 1.4k
Ji‐Young Choe South Korea 19 699 0.9× 290 0.7× 585 1.9× 238 0.9× 252 1.3× 54 1.2k
Irina Linkov United States 15 598 0.7× 531 1.3× 351 1.2× 275 1.0× 257 1.3× 27 1.5k
Byung Woog Kang South Korea 19 508 0.6× 468 1.1× 198 0.7× 347 1.2× 239 1.2× 77 1.2k
Alessandro Bittoni Italy 23 935 1.2× 437 1.1× 488 1.6× 479 1.7× 158 0.8× 93 1.5k
Takeshi Yokoe Japan 20 777 1.0× 507 1.2× 216 0.7× 322 1.2× 134 0.7× 54 1.4k
Thomas Makatsoris Greece 22 1.0k 1.3× 362 0.9× 338 1.1× 198 0.7× 135 0.7× 85 1.5k
Felix Chu United States 12 632 0.8× 588 1.4× 539 1.8× 238 0.9× 251 1.3× 19 1.7k

Countries citing papers authored by Bradley G. Somer

Since Specialization
Citations

This map shows the geographic impact of Bradley G. Somer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley G. Somer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley G. Somer more than expected).

Fields of papers citing papers by Bradley G. Somer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley G. Somer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley G. Somer. The network helps show where Bradley G. Somer may publish in the future.

Co-authorship network of co-authors of Bradley G. Somer

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley G. Somer. A scholar is included among the top collaborators of Bradley G. Somer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley G. Somer. Bradley G. Somer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Stacey A., Pashtoon Murtaza Kasi, Vasily N. Aushev, et al.. (2023). Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer.. Journal of Clinical Oncology. 41(4_suppl). 5–5. 11 indexed citations
2.
Drake, Justin A., Zachary E. Stiles, Stephen W. Behrman, et al.. (2020). The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter?. HPB. 22(11). 1530–1541. 4 indexed citations
3.
Drake, Justin A., Zachary E. Stiles, Jeremiah L. Deneve, et al.. (2020). Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer. Annals of Surgical Oncology. 28(3). 1417–1427. 15 indexed citations
4.
McFarlane, Joshua J., Mark D. Kochenderfer, Mark R. Olsen, et al.. (2020). Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study. Clinical Genitourinary Cancer. 18(6). 469–476.e4. 29 indexed citations
5.
Vogelzang, Nicholas J., Joshua J. McFarlane, Mark D. Kochenderfer, et al.. (2019). Efficacy and safety of nivolumab in patients with non-clear cell renal cell carcinoma (RCC): Results from the phase IIIb/IV CheckMate 374 study.. Journal of Clinical Oncology. 37(7_suppl). 562–562. 13 indexed citations
6.
Dawson, Nancy A., Daniel M. Geynisman, Earle F. Burgess, et al.. (2018). Molecular profiles of small cell bladder and prostate cancer and comparisons with small cell lung cancer.. Journal of Clinical Oncology. 36(6_suppl). 264–264. 1 indexed citations
7.
8.
Bahary, Nathan, Ignacio Garrido‐Laguna, Pelin Cinar, et al.. (2016). Phase 2 trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreas cancer: Interim analysis.. Journal of Clinical Oncology. 34(15_suppl). 3020–3020. 30 indexed citations
9.
Infante, Jeffrey R., Bradley G. Somer, Joon Oh Park, et al.. (2014). A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas. European Journal of Cancer. 50(12). 2072–2081. 271 indexed citations
10.
Houts, Arthur C., Mark S. Walker, Leonardo Nicacio, et al.. (2014). Treatment patterns and clinical effectiveness in metastatic castrate resistant prostate cancer after first-line docetaxel. The Journal of Community and Supportive Oncology. 12(9). 321–328. 4 indexed citations
11.
Schwartzberg, Lee S., Grace Wang, Bradley G. Somer, et al.. (2013). Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer. Clinical Breast Cancer. 14(1). 13–19. 42 indexed citations
12.
Wiechno, Paweł, Bradley G. Somer, Begoña Mellado, et al.. (2013). A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer. European Urology. 65(3). 516–520. 50 indexed citations
13.
14.
15.
Liu, Glenn, et al.. (2009). An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer. Clinical Cancer Research. 15(9). 3172–3176. 146 indexed citations
16.
MacVicar, Gary R., Filippo Greco, James A. Reeves, et al.. (2008). 209 POSTER An open-label, multicenter, phase 1/2 study of AT-101 in combination with docetaxel and prednisone in men with hormone refractory prostate cancer. European Journal of Cancer Supplements. 6(12). 66–66. 2 indexed citations
17.
Somer, Bradley G., et al.. (2003). Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma. Arthritis Care & Research. 49(3). 394–398. 58 indexed citations
18.
Tsai, Donald E., Christine Hardy, John E. Tomaszewski, et al.. (2001). REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1. Transplantation. 71(8). 1076–1088. 272 indexed citations
19.
Feinfeld, Donald A., Bradley G. Somer, Sylvia Wassertheil‐Smoller, et al.. (1998). Serum creatinine and blood urea nitrogen over a six-year period in the very old. PubMed. 8(3). 131–135. 7 indexed citations
20.
Feinfeld, Donald A., Christos P. Carvounis, Robert I. Lynn, et al.. (1995). Sequential Changes in Renal Function Tests in the Old Old: Results from the Bronx Longitudinal Aging Study. Journal of the American Geriatrics Society. 43(4). 412–414. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Rodríguez Breakdown of academic impact, for papers by Vanja Vaccaro Breakdown of academic impact, for papers by Kim A. Reiss Breakdown of academic impact, for papers by Ji‐Young Choe Breakdown of academic impact, for papers by Irina Linkov Breakdown of academic impact, for papers by Byung Woog Kang Breakdown of academic impact, for papers by Alessandro Bittoni Breakdown of academic impact, for papers by Takeshi Yokoe Breakdown of academic impact, for papers by Thomas Makatsoris Breakdown of academic impact, for papers by Felix Chu
Rankless by CCL
2026